Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects
Phase 1
Completed
Conditions
Inflammatory Disease
Interventions
Drug: amilo-5MER
Subscribe
First Posted Date
2023-05-12
Last Posted Date
2023-05-12
Lead Sponsor
Galmed Pharmaceuticals Ltd
Target Recruit Count
55
Registration Number
NCT05857215
Locations
🇬🇧
Quotient Sciences, Mere Way, Ruddington, Nottingham, NG11 6JS, UK, Nottingham, United Kingdom
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy